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The genus Bartonella is composed of fastidious, Gram-
negative and aerobic bacilli belonging to the Alpha
proteobacteria group. Bartonella species (spp.) are
hemotropic, arthropod-borne bacteria that cause long-
term bacteremia in mammalian reservoir hosts [1,2].
During the past decade, there has been a dramatic in-
crease in the number of new Bartonella species that
have been discovered among diverse animal reservoir
hosts in geographical regions throughout the world.
Since 1990, over thirty Bartonella species and sub-
species have been characterized and named, with ma-
ny other putative species yet to be described. Globally,
these bacteria reside in diverse ecological niches; many
cause persistent intravascular infection in reservoir
hosts and 17 Bartonella spp. have been associated with
an expanding spectrum of human and animal diseases,
ranging from acute febrile illnesses to more severe dis-
ease manifestations, including encephalopathy, endo-
carditis, myocarditis, sensory and motor neuropathies,
pleural and pericardial effusion, pneumonia, granuloma-
tous hepatitis and hemolytic anemia [3-7].
The natural history for seemingly all Bartonella spp.
consists of one or more reservoir hosts and one or more
transmission competent arthropod vectors. A vertebrate,
generally a mammal, sustains a chronic intravascular in-
fection, which in some instances is associated with a re-
lapsing pattern of bacteremia. The persistently infected
host serves as the blood reservoir for perpetuation
of the transmission cycle, with an arthropod vector
transferring the bacteria from the reservoir host to a
susceptible uninfected host [8]. Most vectors for Bar-
tonella spp. are arthropods. The vector for B.
quintana is the body louse (Pediculus humanus and
potentially Pediculus capitis) and for B. bacilliformis
is the sandfly (Lutzomyia verrucarum). Fleas (for ex-
ample Ctenocephalides felis on cats and dogs) play a
major role in the natural transmission cycle for many
bartonellae, especially B. henselae among pets and
wildlife [9,10]. There is also a growing spectrum of
arthropods that have been implicated as potential vec-
tors for Bartonella species. Genetic diversity and bac-
terial strain variability appear to enhance the ability
of Bartonella spp. to infect not only specific reservoir
hosts, but also accidental hosts, as has been shown
for B. henselae [11].
Because neurological abnormalities developed in both
children after woodlouse hunter spider bites were sus-
pected by their parents, a family from Kentucky was di-
rected to our laboratory for inclusion in a Bartonella
research study. Three family members were B. henselae
seroreactive and B. henselae DNA was amplified and se-
quenced from the mother and older son’s blood, and
from a woodlouse and woodlouse hunter spiders.Family historical summary
Prior to moving to a new apartment housing location in
suburban Louisville, Kentucky on May 1, 2008, all four
family members were healthy and had normal sleep pat-
terns. Two months earlier, while in a previous apart-
ment, a bat was removed by an exterminator. Although
the bat was flying free within the apartment when
the family awakened, there was no indication of bite
wounds. The family’s dog had also experienced a flea in-
festation prior to moving to the new apartment. The
family dog was the only pet, there was no history of fa-
mily members experiencing bites or scratches and no
flea infestations were reported after moving into the new
apartment or subsequently to a new house in the same
neighborhood.
In July 2008, their new apartment flooded, after which
there was a large influx of woodlice (order Isopoda).
Subsequently, the mother reported seeing occasional
wood louse hunter spiders (Dysdera crocata) in the
apartment, including in the children’s beds and on the
children. During August 2008, the parents suspected
that both sons (5 months-old and 5 years-old, respec-
tively) were bitten by woodlice hunter spiders. The
mother (41 years-old) did not knowingly experience any
spider bites. After the apartment was treated by an ex-
terminator, no woodlice or woodlice hunter spiders were
observed in or around the apartment. Subsequently, the
mother and both sons developed recurrent rash-like skin
lesions, disruptive sleep patterns and both boys devel-
oped anxiety accompanied by episodes of inconsolable
crying, irritability, and panic attacks. In July 2009, the
oldest son was examined by a surgeon because of
enlarged lymph nodes in the neck. Over the ensuing
months, the mother developed symptoms, including fa-
tigue, headaches, joint pain, eye pain, insomnia, memory
loss, disorientation, irritability, weakness in the upper
extremities and loss of sensation to both legs. In May
2010, as detailed in the case report below, the youngest
son was diagnosed with Guillain-Barre syndrome (GBS),
and subsequently with Chronic Inflammatory Demyeli-
nating Polyneuropathy (CIDP).
After contacting the corresponding author and de-
scribing the family's medical history, the mother elected
to enter her sons and herself into an ongoing study
regarding Bartonella spp. infection in patients with
arthropod and animal exposures. (North Carolina State
University Institutional Review Board approval IRB
1960-11). Beginning in August 2011, blood and serum
samples from the mother, both sons and the dog were
submitted for Bartonella testing. As the parent’s initial
concerns related to the youngest son’s CIDP diagnosis,
this child was tested in August 2011, followed by the
mother and dog in November, and the oldest son in
April 2012. The father did not recall being bitten by a
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this investigation and was never tested for evidence
of Bartonella sp. infection. Over a one-year period
(2011–2012), spiders, identified as wood louse hunter
spiders (Dysdera crocata), and several woodlice (Isopoda
order) collected from around the family’s new house
(located three miles from the spider infested apartment)
were submitted by express mail for manual DNA extrac-
tion and Bartonella PCR.
Methods
Samples
Aseptically obtained EDTA (ethylene diaminetetraacetic
acid)-anti-coagulated blood and serum samples from the
family, their dog, whole spiders and woodlice collected
from around the apartment in Kentucky, were sub-
mitted to the North Carolina State University College
of Veterinary Medicine Intracellular Pathogens Research
Laboratory (NCSU-CVM-IPRL) for Bartonella testing.
Collection and analyses of these data were conducted in
conjunction with North Carolina State University Institu-
tional Review Board approval (IRB no. 1960-11).
Serological analyses
Bartonella vinsonii subsp. berkhoffii genotypes I, II, III,
B. henselae (Houston 1strain), B. henselae (San Antonio
2 strain), and Bartonella koehlerae antibodies were
determined in the Intracellular Pathogens Research La-
boratory (IPRL) following traditional immunofluores-
cence antibody assay (IFA) practices with fluorescein
conjugated goat anti-human IgG (Pierce Biotechnology
Rockford IL), as described in previous studies from our
laboratory [12-14]. Bartonella organisms of feline iso-
lates of B.koehlerae (NCSU 09FO-01) and B.henselae
H-1 (NCSU 93FO-23), B. henselae SA2 (NCSU 95FO-
099) and canine isolates of B.vinsonii berkhoffii genotype
I (NCSU 93CO-01), II (NCSU 95CO-08) and III (NCSU
06CO-01) were passed from agar grown cultures into
cell cultures to obtain antigens for IFA testing Heavily
infected cell cultures were spotted onto 30-well Teflon
coated slides (Cel-Line/Thermo Scientific), air dried,
acetone fixed and stored frozen. Serum samples were
diluted in phosphate buffered saline (PBS) solution
containing normal goat serum, Tween-20 and powdered
nonfat dry milk to block non-specific antigen binding
sites. Sera were screened at dilutions of 1:16 to 1:8192.
To avoid confusion with possible non-specific binding
found at low dilutions and to standardize with other la-
boratories such as the CDC, a cutoff titer of 1:64 was
used to define a seroreactive titer.
DNA extraction, PCR assay and DNA sequencing
A previously described approach that combines PCR
amplification of Bartonella spp. DNA from blood, serumand enrichment BAPGM (Bartonella alpha Proteobac-
teria growth medium) enrichment blood culture was
used to test EDTA-anti-coagulated whole blood and
centrifuged serum samples [4,13,15-17]. DNA was auto-
matically extracted from 200 ul of EDTA-anticoagulated
blood, from serum and from 200 ul of BAPGM enrich-
ment blood culture, using a BioRobot Symphony Work-
station and MagAttract DNA blood kit (Qiagen,
Valencia, CA). Prior to extraction of DNA from the
woodlice and wood louse hunter spiders, each individual
specimen was washed twice using 2 ml of dH2O followed
by a single wash with 95% ethanol. For DNA extraction,
the entire body of each arthropod was pulverized to a
fine powder by bead-beating using stainless steel beads.
DNA from spiders and woodlice were manually extracted
using DNeasy blood and tissue mini kit following manu-
facturer’s instructions (Qiagen, Valencia, CA). Bartonella
DNA was amplified using conventional Bartonella genus
PCR primers targeting the 16S-23S intergenic spacer re-
gion (ITS) as previously described [18,19]. Bartonella
genus PCR was performed using oligonucleotides 425 s
(50CCGGGGAAGGTTTTCCGGTTTATCC 30), 325 s
(50 CCTCAGATGATGATCCCAAGCCTTTTGGCG 30)
and 1000as (50 CTGAGCTACGGCCCCTAAATCAGG
30) as forward and reverse primers, respectively. Amplifi-
cation was performed in a 25-ul final volume reaction
containing 12.5 uL of MyTaq Premix (Bioline), 0.2 uL of
100 umol/L of each forward and reverse primer
(IDTWDNA Technology, Coralville, IA, USA), 7.3 uL of
molecular grade water, and 5 uL of DNA from each
sample tested. Conventional PCR was performed in
an Eppendorf Mastercycler EPgradientW (Eppendorf,
Hauppauge, NY, USA) under the following conditions:
a single cycle at 95°C for 2 s, followed by 55 cycles
with DNA denaturing at 94°C for 15 s, annealing at
66°C for 15 s, and extension at 72°C for 18 s. The
PCR reaction was completed by a final cycle at 72°C
for 30s. All PCR reactions were analyzed by 2% agarose
gel electrophoresis. Amplicons obtained from arthropod
and human samples were sequenced to identify the
Bartonella sp. and ITS strain type. Bacterial species and
strains were defined by comparing similarities with other
sequences deposited in the GenBank database using the




In August 2008, the youngest son, a developmentally
normal child with precocious motor skills, sustained
puncture-like bite lesions in the skin overlying the mid
humerus and proximal femur (Figure 1). Based upon
the exposure history and appearance of the lesions,
spider bites were diagnosed by the child’s pediatrician.
Figure 1 Photographs taken by the parents during the
woodlouse and woodlouse hunter spider infestations.
Puncture-like bite lesions were observed in the skin overlying the
mid humerus (A) and proximal femur (B).
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were initially diagnosed as food allergy and was concur-
rently diagnosed with chronic sinusitis. At approximately
24 months of age, (February 2010), his parents first noted
that he would stumble. He also awakened at night crying
and complaining of pain in his legs. Other concerns in-
cluded early morning awakenings, constipation, intermit-
tent complaints of dizziness, and seeing “spots.”
In May 2010, about a month after an upper respiratory
infection, the boy was unable to climb stairs. His parents
brought him to an emergency room, where it was noted
that he was unable to stand from a seated position on
the floor. A lumbar puncture revealed an elevated CSF
protein of 110 (normal 15–45) with 4 white blood cells.
An MRI of the spine demonstrated enhancement of the
ventral nerve roots and pial enhancement from the 11th
thoracic vertebrae through the remainder of the spinal
cord. Neurological examination was significant for are-
flexia and weakness in the lower extremities. Guillain-
Barre Syndrome was diagnosed and he was treated with
2 grams per kilogram of intravenous gammaglobulin
(IVIG) over 4 days. He improved rapidly and was dis-
charged following the infusions.
When re-examined one month later, his leg strength
was judged to be improved to 85% of normal and no fur-
ther treatment was given. By July 2010, he was less able
to walk without stumbling and was unable to stand from
a seated position. He also complained of tingling and
discomfort around his mouth and pain in the legs. IVIG
was administered at a dose of 1 gram/kilogram on
each of 2 days. Electromyelogram (EMG) findings were
consistent with chronic sensory motor demyelinating
polyneuropathy with secondary axonal features and con-
duction block. CIDP was diagnosed and IVIG treatments
were re-instituted every 4 weeks, along with a 4 week
course of prednisone and gabapentin for pain. By May
2011, following internet searches, his mother became
concerned that the boy’s symptoms might be related to
Bartonella infection. Due to this concern, treatment with
azithromycin was initiated for 10 days, and it was feltthat this was associated with some improvement. Bar-
tonella henselae IgM and IgG antibodies were not de-
tectable at a 1:16 dilution (ARUP Laboratories, Salt Lake
City Utah). By July 2011, despite medical therapy, pain
and the right foot drop had worsened.
When he had another relapse of muscle weakness,
IVIG was administered on August 19, 2011, ten days
prior to obtaining blood for additional Bartonella testing
at the NCSU-CVM-IPRL. While awaiting test results,
treatment with azithromycin for 30 days was reinitiated.
The family felt that they noted almost immediate im-
provement of the patient’s symptoms and requested
that the next IVIG treatment be delayed. The boy was
seroreactive to multiple Bartonella spp. antigens (see
below, Table 1). A decision was made to decrease the
dose of the IVIG to 1 g/kg and stretch the infusions to
every 6 weeks with the first infusion at this dose being
administered in October 2011. It was rapidly clear that
this would not be successful as weakness and symptoms
of burning pain in his legs returned. Infusions were then
reinitiated at a dose of 2 g/kg every 4 weeks and then
stretched to every 5 weeks in July 2012. The addition of
prednisone was avoided due to concern that immune
suppression might interfere with therapeutic elimination
of the suspected Bartonella infection. After IVIG infu-
sion was reinitiated at the full dose in late 2011 the pa-
tient’s muscle strength continued to improve. In May
2012, treatment with clarithromycin 125 mg twice daily
and rifampin 150 mg twice daily was instituted. By July
2012, his deep tendon reflexes had returned and his
strength was normal. As his pain was diminished, ga-
bapentin was discontinued. Clarithromycin and rifampin
have been well tolerated and both drugs were continued
through November 2012. As of this writing, the child is
ambulating normally, but still occasionally complains of
stiffness and joint pain in his legs, particularly when
he wakes up in the morning. As of January 31, 2013,
polyneuropathy remains in remission and IVIG has not
been administered since September 14, 2012. The par-
ents report that the child is actively socializing with
other children and now runs and plays like he had never
done before.
Mother
The mother, who takes care of her children and home
full-time, was healthy prior to August 2008. She re-
ported limited exposure to cats, wildlife or production
animals, but did allow the family dog to sleep in her bed.
Prior vector exposure was infrequent, but included fleas,
ticks and mosquitoes. She did not recall being bitten by
a spider. Subsequent to the spider infestation of the
apartment, she developed fatigue, memory difficulties,
headaches, irritability, eye pain, insomnia, chest pain,
blurred vision, shortness of breath, rash and skin lesions
Table 1 Serological, PCR and culture results from the three patients and their family dog
Family members Date Sample PCR/BAPGM culture resultsa Bartonella IFA reciprocal titers
Direct Enrichment Bvb I Bvb II Bvb III BhHI BhSA2 Bk
extraction culture
Youngest Son 8/29/2011 Serum Neg N/D <16 <16 <16 256 256 128
Blood Neg Neg
8/31/2011 Serum Neg N/D 64 1024 128 512 512 2048
Blood Neg Neg
9/2/2011 Serum Neg N/D 32 512 128 256 256 512
Blood Neg Neg
11/21/2012 Serum Neg Neg <16 <16 <16 <16 64 <16
Blood Neg Neg
Mother 11/14/2011 Serum Neg N/D <16 32 <16 <16 64 <16
Blood Neg Neg
11/16/2011 Serum Bh N/D 32 128 64 64 64 32
Blood Neg Neg
11/18/2011 Serum BhSA2 N/D 32 256 32 32 64 64
Blood Neg Neg
Oldest Son 4/16/2012 Serum Neg N/D <16 256 <16 <16 128 <16
Blood Neg Neg
4/18/2012 Serum Neg N/D <16 256 <16 <16 128 <16
Blood Neg BhSA2
4/20/2012 Serum Neg N/A <16 256 <16 <16 128 <16
Blood BhSA2 Neg
Dog 11/23/2011 Serum N/D N/D <16 <16 <16 <16 <16 <16
Blood Neg Neg
a Denotes 16S-23S ITS DNA sequence results.
Bh = Bartonella henselae, Bh SA2 = Bh strain San Antonio, Bh HI = Bh strain Houston I.
Bvb I, II, and III = Bartonella vinsonii subsp. berkhoffii genotype I, II, and III.
Bk = Bartonella koehlerae.
N/D = Not done.
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sensation in her legs, joint pain involving the shoulders
and ankles, ear pain, and she frequently had a sore
throat. In July 2009, she was examined due to an ab-
dominal rash and shingles was tentatively diagnosed.
The mother reported that her symptoms persisted be-
tween 2008–2011, without notable improvement or de-
terioration, during which time she sought care from her
family physician, an otolaryngologist and a neurologist.
Using blood and serum samples submitted in November
2011, infection with B. henselae (SA2 strain) was con-
firmed serologically and by PCR amplification and DNA
sequencing. Between February and July 2012, she was
treated with doxycycline 200 mg once daily and rifampin
300 mg twice a day. Following this antibiotic course, the
mother reported substantial overall improvement and
was almost symptom free. However, she continues to
experience occasional irritability, confusion, dizziness,nausea, and pain involving the shoulder, hip and the bot-
toms of her feet.
Oldest son
In August 2008, the older son, was examined by his
pediatrician due to suspected spider bites and a rash.
This child also had occasional exposure to cats and dogs
and had exposure to fleas and mosquitoes. Subsequently,
the boy complained of a sore throat, occasional ear pain
and pain in the thigh region. In July 2009, the boy’s par-
ents sought medical consultation with a dentist and sur-
geon for a swollen lymph node in the neck that had
persisted for approximately 3 months. The lymph node
regressed in size without therapy. During 2009–2012,
the parents indicated that the boy experienced episodes
of unexplained depression, irritability, and anxiety, but
was otherwise healthy. Infection with B. henselae SA2
strain was confirmed by serology and BAPGM enrichment









1 9/28/2011 Bh SA2 1 9/8/2011 Neg
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3 Bvb III 3 Neg







11 10/8/2012 Bh SA2
12 Neg
13 Neg
a Denotes 16S-23S ITS DNA sequencing results.
Bh SA2 = Bartonella henselae strain San Antonio 2.
Bvb III = Bartonella vinsonii subsp. berkhoffii genotype III.
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rithromycin 250 mg twice daily was instituted in May
2012. On August 29, 2012, rifampin 300 mg twice daily
was added to the treatment regimen, which has continued
through November, without known adverse side effects.
The sore throat, ear and eye pain resolved by October;
however, during the fall 2012 school year, his parents
reported increased irritability and rage episodes. In ad-
dition, the boy’s teacher indicated a lack of attention du-
ring class, and suggested that the child might have an
Attention Deficit Hyperactivity Disorder (ADHD). After
consultation with the attending physician and a psychia-
trist, the parents declined therapy for ADHD.
Bartonella spp. serology and BAPGM enrichment PCR
results
Bartonella serology and PCR results for the three family
members and the dog are summarized in Table 1. The
youngest son was seroreactive to B. henselae SA2, B.
henselae HI and between August 29th and August 31st,
there was a four-fold or greater increase in antibody ti-
ters to B. koehlerae and to B. vinsonii subsp. berkhoffii
genotypes I, II, and III. Bartonella sp. DNA was not
amplified from his blood, serum or BAPGM enrichment
blood cultures. The mother was seroreactive to B. hen-
selae HI, B. henselae SA2, B. vinsonii subsp. berkhoffii
genotypes II and III and B. koehlerae. Bartonella hen-
selae bacteremia was confirmed in the mother by PCR
amplification from two BAPGM enrichment blood cul-
tures. Based upon the amplified DNA sequences, the B.
henselae strain in the mother’s samples were 99.8% and
100% similar, respectively to B. henselae SA2, (GenBank
accession AF369529). The oldest son was seroreactive to
B. henselae SA2 and B. vinsonii subsp. berkhoffii geno-
type II. Based upon the DNA sequences amplified from
a blood sample and BAPGM enrichment blood culture
sample, the oldest son was bacteremic with a B. henselae
SA2 strain (99.2% and 99.6% homology with GenBank
accession AF369529). The dog was seronegative to all
Bartonella spp. antigens and no Bartonella DNA was
amplified from blood or the BAPGM enrichment blood
culture. Following BAPGM enrichment culture, no sub-
culture isolates were obtained from any family member.
When retested in November 2012, the youngest son
was only seroreactive to the B. henselae SA2 strain and
Bartonella sp. DNA was not amplified from blood,
serum or the BAPGM enrichment blood culture.
PCR testing of woodlice and wood louse hunter spiders
Bartonella henselae SA2 DNA (97.0% homology with
GenBank accession AF369529) was amplified and se-
quenced from pooled woodlice (Table 2). Of the thirteen
wood louse spiders tested, B. henselae SA2 DNA (100%
and 99.3% homology, Gen Bank accession AF369529)was amplified and sequenced from two spiders and B.
vinsonii subsp. berkhoffii genotype III DNA (98.6% hom-
ology, GenBank accession DQ059765) from one spider.
As the family had moved from the apartment in which
the bites occurred into a house, all of the spiders and
woodlice were collected approximately 3 miles from the
original suspected spider bite location.
Discussion
PCR amplification and sequencing of B. henselae SA2
DNA from two family members, woodlouse hunter spi-
ders, and a woodlouse collected at least three years after
family members were exposed to and the children were
presumably bitten by similar spiders, was unexpected.
To the best of our knowledge, this is the first report of
the presence of Bartonella spp. DNA in spiders or in
woodlice. Although B. henselae DNA was amplified from
two spiders collected 13 months apart, a woodlouse, and
from serum, blood and BAPGM enrichment culture
samples from two family members, these results should
be interpreted with caution, as it is not clear whether
Bartonella was acquired at the time of the infestation
and spider bites or whether the spiders and woodlice are
accidental hosts for Bartonella spp. Since the woodlouse
hunter spider is thought to feed exclusively on woodlice
(a land-dwelling crustacean), the amplification of Bar-
tonella DNA from spiders and woodlice suggests that
the B. henselae-infected spiders fed on infected woodlice.
Preliminary results (unpublished data) obtained in our
laboratory indicates that washed woodlice can become
PCR-positive for B. henselae after feeding on food con-
taminated with the bacteria. Although the length of time
that B. henselae can remain viable within the environment
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remains viable in flea feces for several days. Whether bac-
teria ingested by woodlice remain viable, whether replica-
tion can occur, how long a Bartonella sp. can be retained
within the isopod and whether a spider feeding on this
crustacean can acquire or transmit Bartonella are subjects
for future studies. Although the family experienced a flea
infestation prior to moving into the new apartment, the
family dog was not seroreactive to Bartonella sp. antigens
and was PCR negative in blood and BAPGM enrichment
blood culture, making the dog and potentially fleas a less
likely source of B. henselae transmission to family mem-
bers. To date, B. henselae has not been reported in bats to
the author’s knowledge, no family member experienced a
bat bite, and the bat exposure occurred several months
before the onset of illness in the children and mother.
Bartonella DNA has also been amplified from non-
hematophagous arthropods, such as honey bees [20].
Those authors hypothesized that honey bees ingested or
acquired Bartonella organisms through environmental
contact. In a recent report, a patient with neuroretinitis,
a well documented ocular pathology induced by B.
henselae, was diagnosed with bartonellosis following the
bite (sting) of a bull ant (genus Myrmecia) in Australia
[21]. These authors suggested that B. henselae was prob-
ably transmitted to the patient via the stinger or mandi-
bles, which provided a portal for bacterial entry into the
skin. These recent publications indicate that physicians
should routinely review a patient’s medical history for
arthropod exposure. Based upon recent clinical and
research observations, there appears to be a growing
spectrum of arthropods that might serve as vectors for
Bartonella species, thereby emphasizing the critical im-
portance of and the need for additional experimentally
controlled vector competence studies. In addition, loca-
lizaton of Bartonella sp. replication within arthropods,
further documentation of other potential animal reser-
voirs, and the determination of trans-ovarian trans-
mission in various arthropod species represent other
important issues that require scientific attention.
From a clinical perspective, the non-specific symptoms
reported in the mother are consistent with previous re-
ports of Bartonella sp. bacteremia in immunocompetent
patients [4,22]. Although less well characterized, the
behavioral and neurocognitive abnormalities that predo-
minated in the older son have also been reported in
Bartonella bacteremic children [14,23,24]. Interestingly,
and as reported in a small subset of patients in two case
series, B. henselae DNA was only amplified from the
mother's extracted serum samples, whereas B. henselae
DNA was amplified from both blood and a BAPGM en-
richment blood culture from the oldest son [4,22]. The
reason(s) for these observations remain unclear, but one
study has reported progressive increases in serum DNAconcentration in association with prolonged sample sto-
rage times in certain pathologic conditions [25]. Barto-
nella DNA was never amplified from a negative control
and DNA from a B. henselae H1 strain (not B. henselae
SA2 as found in this study) was used as a positive con-
trol for all PCR testing, therefore laboratory contamin-
ation is an unlikely explanation for the PCR and DNA
sequencing results reported in this study. Due to the fact
that B. henselae induces a relapsing bacteremia in cats
[26] and B. birtlesii induces a relapsing bacteremia in ex-
perimentally infected rodents [27], three blood samples
obtained at approximately 2 day intervals were tested for
each patient. For the mother and oldest son, only two
dates yielded positive PCR results, potentially supporting
the possibility of a relapsing pattern of B. henselae bac-
teremia in human patients. Also, as reported previously
from our laboratory [28], there was considerable vari-
ability in the mother’s and youngest son’s antibody titers
when serum samples obtained within a one-week time
frame were tested using an IFA technique. The mother
had low antibody titers with up to four-fold variations in
four of the six Bartonella spp. antigens over a one week
period. The youngest son had identical antibody titers to
B. henselae strains H1 and SA2, but seemingly sero-
converted to B. vinsonii subsp. berkhoffii genotypes I, II
III and B. koehlerae. Administration of IVIG ten days
prior to collection of the initial blood sample may well
have influenced the youngest son’s serological results,
particularly if IVIG has antibacterial properties [29]. In
contrast, the oldest son’s antibody titers were identical
for all six antigens at all three time points. In the context
of antigenic specificity, he had antibodies to B. henselae
SA2 strain, but not to a B.henselae H1 strain. All serum
sample sets from each patient were tested at the same
time, by the same experienced technician, using the
same conjugate and IFA antigen slides. Whether these
serological discrepancies are related to sample collection
and storage issues, a prozone effect associated with ex-
cess antigen, IVIG or other unknown factors requires
additional investigation.
Similar to the initial diagnosis in the youngest son,
GBS due to neurobartonellosis was diagnosed in a
10-year-old girl, who was hospitalized due to progressive
leg weakness [30]. Seven days earlier, the girl had a self-
limiting episode of fever and vomiting of 1 day duration.
Four days later, she had difficulty walking, became irri-
table and complained of severe myalgia in the lower
limbs. Laboratory findings were not remarkable. Nerve
conduction studies identified decreases in motor con-
duction velocity and amplitude, consistent with axonal
damage. An exhaustive search for known causes of GBS
was negative. The girl was treated with IVIG for 5 days,
and within two weeks her neurological status had norma-
lized. There was no history of cat scratches, no palpable
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abdominal ultrasound, however, because she lived in a
rural area and played with kittens, B. henselae serology
was requested. Her B. henselae IgG titer was 1:1024 and a
specific IgM titer was “positive”, although a value was not
reported. Her convalescent IgM titer was negative and the
IgG antibody titer had decreased. To date, CIDP has not
been associated with Bartonella infection. Although ser-
ology supported Bartonella exposure in the younger son,
prior administration of IVIG complicates interpretation of
his antibody titers and potentially his BAPGM enrichment
culture PCR test results. It is possible that the source of
Bartonella antibodies was the IVIG and that repeated im-
munoglobulin administration suppressed the level of bac-
teraemia below the level of successful PCR amplification.
CIPD, also referred to as relapsing polyneuropathy, is a
neurological disorder characterized by progressive weak-
ness and impaired sensory function in the legs and arms.
As was true in the boy in this report, CIPD is often diag-
nosed as the chronic counterpart of GBS. Prior infection
or vaccination can precipitate GBS, and Campylobacter
jejuni has become the most well recognized antecedent in-
fection [31]. Consideration should be given to B. henselae
as an antecedent infection for GBS and CIPD. Physicians
should pursue the medical history in these patients to de-
termine if they have experienced animal bites or scratches
or arthropod bites or stings.
As scientists, physicians and veterinarians learn more
about the medical importance of the genus Bartonella,
there has been enhanced focus on known and suspected
arthropod vectors. Because of their ability to reside
within erythrocytes of a diverse number of mammalian
hosts in conjunction with their diverse ecological niches,
there is the potential opportunity for various Bartonella
spp. to be transmitted by a variety of arthropod vectors.
Several blood-feeding arthropods, Lutzomyia verruca-
rum, Pediculus humanus humanus, Ctenocephalides felis
and some rodent fleas (Ctenophthalmus nobilis) have
been confirmed to be competent vectors for transmis-
sion of Bartonella species [32]. Tick transmission of
Bartonella spp. has been a controversial subject in re-
cent years [33,34]; however, vector competence for tick
(Ixodes ricinus) transmission of a Bartonella sp. was re-
cently demonstrated experimentally, thus supporting the
possibility that Ixodes sp. ticks are transmitting Bar-
tonella spp. throughout the northern hemisphere [35].
Previous studies from Europe and North America have
documented the presence of B. henselae DNA in Ixodes
ricinus [36] Ixodes scapularis [37] and Ixodes pacificus
[38]. In conclusion, it must be stressed that there is an
important difference between the vector competence
and vector potential of arthropods from which Bar-
tonella spp. DNA is amplified. The amplification of
Bartonella spp. DNA in the woodlouse hunter spiders inthis study does not provide definitive proof of vector
competence and may merely represent an accidental in-
fection associated with ingestion of Bartonella-infected
blood from an infected host (isopod). Although B. hen-
selae was amplified and sequenced from woodlouse hun-
ter spiders and from their associated prey, the woodlouse,
definitively establishing the source of bacterial transmis-
sion to this family was not possible.
Conclusions
There appears to be a growing spectrum of arthropods
that might serve as vectors for various Bartonella species.
The location of Bartonella replication within arthropods,
the documentation of other potential reservoirs, and the
determination of trans-ovarian transmission in various
arthropod species represent important public health issues
that need to be resolved. As B. henselae SA2 DNA was
amplified from woodlouse spiders and from a woodlouse
collected nearly three years after the reported bites, it is
not clear if the B. henselae infections in this family were
acquired by spider bites or whether spiders and woodlice
were accidental hosts. Also, additional studies are nee-
ded to determine whether B. henselae bactermia can
predispose patients to GBS, CIDP and neurocognitive
abnormalities.
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Written informed consent was obtained from the patient
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were full supportive of investigations described in this
manuscript.
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